Others - Finance

As we move closer and closer to the final implementation of the Bankruptcy Reform Act, many US citize

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ns are making a mad dash to their local attorney's office. Rightfully so, as the Bankruptcy Reform Ac

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

t will institute many changes that will ultimately make the declaration of bankruptcy a much more dif

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ficult task. But as you ponder the notion of a flood of bankruptcy filings, also realize that many of

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

the major credit card issuers in the country are making changes to their guidelines that will cause

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

monthly payments to go up and in many cases, almost double.

For years minimum payments have been set

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

at roughly 2% - 2.5% of a persons total debt. So if you owed $10,000 you were paying roughly $200 pe

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

r month. Now with guidelines changing a person could be required to pay 4% or more each month toward

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

s their credit card debt. Using the same example that would mean that the same $10,000 debt would re

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

quire a $400 payment each month.

Although it is not an astronomical change, for those people who are

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

living minimum payment to minimum payment this could be a crippling blow to their wallets. Another t

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

hing to consider is that most people are unaware of this upcoming change, meaning that they may or ma

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

y not be able to make that payment on time. As we all know, if you don't pay on time, you will pay th

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

e fine.

Realize as well, that being charged a late fee is almost always coupled with an interest rat

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

e hike. This 1-2 punch from credit card issuers has an eerie timing about it. The government is going

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

to make it more difficult for people to declare bankruptcy, and the banks are making changes that mi

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ght cause more people need bankruptcy. It isn't difficult to see how these two changes together can,

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

and most likely will, have a dramatic impact on the rest of the US and our commerce. No matter what t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

he outcome proves to be, it is quite apparent that timing is everything.

For more information please

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

visit: solveyourcreditproblems.com

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

The 7 keys to unlock your business success. Discover how to break through the growth barriers and develop a business that provides unlimited potential, wealth and freedom from day to day pressures. You should not go back to work until you discover the 7 keys for yourself.

Affiliate Marketing is having Affiliates do your Marketing for you. What I mean by Affiliate is someone who tells people about your product/service and you pay them for a desired response, such as a purchase.

In a world where things are never quite what they appear to be, the internet has proven to be a very mysterious place. Large and powerful corporations like Microsoft, Apple, and Google are running the show, but their websites are surprisingly easy to imitate by any freelance artist for any teeny-tiny business owner. Any person can have a website that makes them seem larger than they really are

Tags

Links

Others - Timing is Everything

Related Articles: